Ophthalmic compositions for treating ocular hypertension

Details Ophthalmic compositions for treating ocular hypertension Ophthalmic compositions for treating ocular hypertension

2004-08-31

2009-02-24

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C514S089000, C514S338000, C514S406000, C546S022000, C546S024000, C548S113000

Reexamination Certificate

active

07494983

ABSTRACT:
This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.

REFERENCES:
patent: 4690931 (1987-09-01), Wick et al.
patent: 5151444 (1992-09-01), Ueno et al.
patent: 5296504 (1994-03-01), Stjernschantz et al.
patent: 5352708 (1994-10-01), Woodward et al.
patent: 5422368 (1995-06-01), Stjernschantz et al.
patent: 5573758 (1996-11-01), Adorante et al.
patent: 5889052 (1999-03-01), Klimko et al.
patent: 5925342 (1999-07-01), Adorante et al.
patent: 1114816 (2001-07-01), None
patent: WO 89/10757 (1989-11-01), None
patent: WO 94/13275 (1994-06-01), None
patent: WO 94/28900 (1994-12-01), None
patent: WO 96/33719 (1996-10-01), None
patent: WO 01/70702 (2001-09-01), None
patent: WO 01/72268 (2001-10-01), None
patent: WO 02/24647 (2002-03-01), None
patent: WO 02/42268 (2002-05-01), None
patent: WO 01/46140 (2004-06-01), None
patent: WO 2004/085431 (2004-10-01), None
Wiederholt et al. (Progress in Retinal & Eye Research 2000, 19(3), 271-295).
A. M. Harman et al., “Development and Aging of Cell Topography in the Human Retinal Pigment Epithelium”, 1997, pp. 2016-2026, vol. 38, No. 10, Investigative Ophthalmology & Visual Science.
E. L. Eliel et al., “Chirality in Molecules Devoid of Chiral Centers”, 1994, pp. 1119-1190, Chap. 14,Stereochemistry of Organic Compounds.
S. M. Berge et al., “Pharmaceutical Salts”, 1977, pp. 1-19, vol. 66, No. 1, J. of Pharmaceutical Sciences.
H. Eto et al., “New Antifungal 1,2,4-Triazoles with Difluoro (heteroaryl) methyl Moiety”, 2000, pp. 982-990, vol. 48, No. 7, Chem. Pharm. Bull.
O. P. Hamill et al., “Improved Patch Claim Techniques for High-Resolution Current Recording from Cells and Cell-Free Membrane Patches”, 1981, pp. 82-100, vol. 391, Pflugers Archiv.

Affiliated with

Also associated with

Rating

Ophthalmic compositions for treating ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic compositions for treating ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions for treating ocular hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4131122